Millet, A.; Khoudour, N.; Lebert, D.; Machon, C.; Terrier, B.; Blanchet, B.; Guitton, J.
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma. Molecules 2021, 26, 1383.
https://doi.org/10.3390/molecules26051383
AMA Style
Millet A, Khoudour N, Lebert D, Machon C, Terrier B, Blanchet B, Guitton J.
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma. Molecules. 2021; 26(5):1383.
https://doi.org/10.3390/molecules26051383
Chicago/Turabian Style
Millet, Aurélien, Nihel Khoudour, Dorothée Lebert, Christelle Machon, Benjamin Terrier, Benoit Blanchet, and Jérôme Guitton.
2021. "Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma" Molecules 26, no. 5: 1383.
https://doi.org/10.3390/molecules26051383
APA Style
Millet, A., Khoudour, N., Lebert, D., Machon, C., Terrier, B., Blanchet, B., & Guitton, J.
(2021). Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma. Molecules, 26(5), 1383.
https://doi.org/10.3390/molecules26051383